Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Personalizing Immune Checkpoint Inhibitor Therapy for Solid Tumors

NCT03409341 is registered in ClinicalTrials.gov with Holy Cross Hospital, Maryland as lead sponsor.

NCT NCT03409341
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03409341 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Personalizing Immune Checkpoint Inhibitor Therapy for Solid Tumors
Lead sponsor
Holy Cross Hospital, Maryland
Phase
Observational
Overall status
Withdrawn
Start date
February 1, 2019
Completion date
September 22, 2020
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer stage iv